Suchergebnisse - "Shiffman, Mitchell L"

PubPharm (421)

1

Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis

enthalten in: The New England journal of medicine | 2024

von Kowdley, K. | Bowlus, C. | Levy, C. | +102

2

Open-label, clinical trial extension : Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis

enthalten in: Alimentary pharmacology & therapeutics | 2024

von Mayo, M. | Vierling, J. | Bowlus, C. | +20

3

Open‐label, clinical trial extension : Two‐year safety and efficacy results of seladelpar in patients with primary biliary cholangitis

enthalten in: Alimentary Pharmacology & Therapeutics | 2024

von Mayo, M. | Vierling, J. | Bowlus, C. | +20

4

enthalten in: Alimentary Pharmacology & Therapeutics | 2024

von Mayo, M. | Vierling, J. | Bowlus, C. | +20

5

Autoimmune Hepatitis : Epidemiology, Subtypes, and Presentation

enthalten in: Clinics in liver disease | 2024

von Shiffman, M.

6

Real-world use of avatrombopag in patients with chronic liver disease and thrombocytopenia undergoing a procedure

enthalten in: Medicine | 2023

von Satapathy, S. | Sundaram, V. | Shiffman, M. | +1

7

Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis : ENHANCE, a phase 3, randomized, placebo-controlled study

enthalten in: Hepatology (Baltimore, Md.) | 2023

von Hirschfield, G. | Shiffman, M. | Gulamhusein, A. | +138

8

Safety and Sustained Efficacy of the Farnesoid X Receptor (FXR) Agonist Cilofexor Over a 96-Week Open-label Extension in Patients With PSC

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2023

von Trauner, M. | Bowlus, C. | Gulamhusein, A. | +12

9

A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis

enthalten in: Journal of hepatology | 2022

von Bowlus, C. | Galambos, M. | Aspinall, R. | +21

CommentIn: J Hepatol. 2022 Nov;77(5):1451. - PMID 35594993

10

A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C : The PRIORITIZE Study

enthalten in: Hepatology (Baltimore, Md.) | 2021

von Sulkowski, M. | Moon, J. | Sherman, K. | +25

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[43]